KriSan Biotech

Founded in 2015, KriSan Biotech specializes in complex drug process development and GMP production. With over 20 years of expertise developing novel drug processes, KriSan’s core competency lies in Complex Small Molecules, peptides, oligonucleotides, antibody-drug conjugates (ADC), and peptide-drug conjugates (PDC).
KriSan provides exceptional and customer-oriented services throughout the new drug development cycle, including process development, scale-up, analytical development, stability programs, cGMP production, and regulatory support.
The team adheres to international regulatory and quality standards, and the KriSan facility is certified with PIC/s GMP. KriSan aims to provide worldwide customers with drug substances needed starting from pre-clinical phases and extending all the way to commercialization. The successful delivery of approximately 100 APIs supported 50+ companies in clinical trials across the United States, European, Australia, Japan, Singapore, and Taiwan.
KriSan is a preferred CDMO service partner, and stands as a Total-Solution and One-Stop Shop, poised to meet clients' diverse requirements